Letermovir 240mg tablets
NHS hospitals in England used £21,858,726 of indicative cost of Letermovir 240mg tablets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 3.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Letermovir 240mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Letermovir 240mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Manchester University Nhs Ft | £2,748,357 |
| King's College Hpl Nhs Foundation Trust | £1,819,694 |
| Imperial College Healthcare Nhs Trust | £1,704,941 |
| University College London Foundation Tr | £1,554,962 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,448,442 |
| Cambridge Univ Hosp Nhs Foundation Trust | £1,361,347 |
| The Christie Nhs Foundation Trust | £1,335,684 |
| The Royal Marsden Nhs Foundation Trust | £1,135,564 |
| Barts Health Nhs Trust | £1,056,580 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,007,514 |
The primary-care picture
Letermovir is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Letermovir medicine page.